MedTrace Logo

Exploring Pathogenesis and Treatment of Hypercalcemia Caused by Intramuscular Injection of Paraffinoil

NCT04265599 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2024-10-01

No results posted yet for this study

Summary

The aim of the study is to characterize paraffin oil induced granulomatous disease. We will investigate pathogenesis and natural history of paraffin disease. Subsequently, through further translational studies, we intend to identify novel treatments to be tested in future randomized clinical trials.

Conditions

  • Hypercalcemia
  • Renal Injury
  • Paraffinoma

Sponsors & Collaborators

  • Herlev Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-30
Primary Completion
2027-01-31
Completion
2027-01-31

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04265599 on ClinicalTrials.gov